Literature DB >> 27538743

Harnessing the Power of Cruciferous Vegetables: Developing a Biomarker for Brassica Vegetable Consumption Using Urinary 3,3'-Diindolylmethane.

Naomi Fujioka1, Benjamin W Ransom2, Steven G Carmella2, Pramod Upadhyaya2, Bruce R Lindgren2, Astia Roper-Batker3, Dorothy K Hatsukami4, Vincent A Fritz5, Charles Rohwer6, Stephen S Hecht2.   

Abstract

Glucobrassicin in Brassica vegetables gives rise to indole-3-carbinol (I3C), a compound with potent anticancer effects in preclinical models. We previously showed that the urinary metabolite 3,3'-diindolylmethane (DIM) could discriminate between volunteers fed high and low doses of Brassica vegetables. However, the quantitative relationship between glucobrassicin exposure and urinary DIM level is unclear. We conducted a clinical trial to examine the hypotheses that a range of glucobrassicin exposure from Brassica vegetables is reflected in urinary DIM and that this effect plateaus. Forty-five subjects consumed vegetables, a mixture of brussels sprouts and/or cabbage, at one of seven discrete dose levels of glucobrassicin ranging from 25 to 500 μmol, once daily for 2 consecutive days. All urine was collected for 24 hours after each vegetable-eating session. Urinary DIM was measured using our published liquid chromatography-electrospray ionization-tandem mass spectrometry-selected reaction monitoring (LC/ESI-MS/MS-SRM) method. Urinary DIM excretion increased predictably with increasing glucobrassicin dose and plateaued between 200 and 300 μmol of glucobrassicin. The association between glucobrassicin dose and urinary DIM was strong and positive (R2 = 0.68). The majority of DIM was excreted in the first 12 hours after vegetable consumption. We conclude that urinary DIM is a reliable biomarker of glucobrassicin exposure and I3C uptake and that feeding glucobrassicin beyond 200 μmol did not consistently lead to more urinary DIM, suggesting a plateau in potential chemopreventive benefit. Cancer Prev Res; 9(10); 788-93. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27538743      PMCID: PMC5220883          DOI: 10.1158/1940-6207.CAPR-16-0136

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  29 in total

Review 1.  Notes from the field: "green" chemoprevention as frugal medicine.

Authors:  Jed W Fahey; Paul Talalay; Thomas W Kensler
Journal:  Cancer Prev Res (Phila)       Date:  2012-02

2.  Oligomerization of indole-3-carbinol in aqueous acid.

Authors:  K R Grose; L F Bjeldanes
Journal:  Chem Res Toxicol       Date:  1992 Mar-Apr       Impact factor: 3.739

Review 3.  Molecular targets and anticancer potential of indole-3-carbinol and its derivatives.

Authors:  Bharat B Aggarwal; Haruyo Ichikawa
Journal:  Cell Cycle       Date:  2005-09-06       Impact factor: 4.534

4.  Urinary 3,3'-diindolylmethane: a biomarker of glucobrassicin exposure and indole-3-carbinol uptake in humans.

Authors:  Naomi Fujioka; Cheryl E Ainslie-Waldman; Pramod Upadhyaya; Steven G Carmella; Vincent A Fritz; Charles Rohwer; Yunhua Fan; Diane Rauch; Chap Le; Dorothy K Hatsukami; Stephen S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-19       Impact factor: 4.254

5.  Long-term responses of women to indole-3-carbinol or a high fiber diet.

Authors:  H L Bradlow; J J Michnovicz; M Halper; D G Miller; G Y Wong; M P Osborne
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Oct-Nov       Impact factor: 4.254

6.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Adv Enzyme Regul       Date:  1984

7.  Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans.

Authors:  J J Michnovicz; H Adlercreutz; H L Bradlow
Journal:  J Natl Cancer Inst       Date:  1997-05-21       Impact factor: 13.506

8.  Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer.

Authors:  Kathie M Dalessandri; Gary L Firestone; Mark D Fitch; H Leon Bradlow; Leonard F Bjeldanes
Journal:  Nutr Cancer       Date:  2004       Impact factor: 2.900

9.  Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol.

Authors:  J J Michnovicz; H L Bradlow
Journal:  Nutr Cancer       Date:  1991       Impact factor: 2.900

10.  Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats.

Authors:  D M Stresser; D E Williams; D A Griffin; G S Bailey
Journal:  Drug Metab Dispos       Date:  1995-09       Impact factor: 3.922

View more
  6 in total

1.  Identification and analysis of a mercapturic acid conjugate of indole-3-methyl isothiocyanate in the urine of humans who consumed cruciferous vegetables.

Authors:  Pramod Upadhyaya; Adam T Zarth; Naomi Fujioka; Vincent A Fritz; Stephen S Hecht
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-12-02       Impact factor: 3.205

Review 2.  Isothiocyanates: Translating the Power of Plants to People.

Authors:  Dushani L Palliyaguru; Jian-Min Yuan; Thomas W Kensler; Jed W Fahey
Journal:  Mol Nutr Food Res       Date:  2018-03-26       Impact factor: 5.914

3.  T-cell expression of AhR inhibits the maintenance of pTreg cells in the gastrointestinal tract in acute GVHD.

Authors:  Trisha A Dant; Kaifeng L Lin; Danny W Bruce; Stephanie A Montgomery; Oleg V Kolupaev; Hemamalini Bommiasamy; Lisa M Bixby; John T Woosley; Karen P McKinnon; Frank J Gonzalez; Bruce R Blazar; Benjamin G Vincent; James M Coghill; Jonathan S Serody
Journal:  Blood       Date:  2017-05-26       Impact factor: 22.113

4.  Strain-specific altered nicotine metabolism in 3,3'-diindolylmethane (DIM) exposed mice.

Authors:  A Joseph Bloom; Pramod Upadhyaya; Evan D Kharasch
Journal:  Biopharm Drug Dispos       Date:  2019-05-20       Impact factor: 1.627

5.  Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.

Authors:  Justine M Grixti; Steve O'Hagan; Philip J Day; Douglas B Kell
Journal:  Front Pharmacol       Date:  2017-03-27       Impact factor: 5.810

6.  Employing Dietary Comparators to Perform Risk Assessments for Anti-Androgens Without Using Animal Data.

Authors:  Matthew P Dent; Hequn Li; Paul L Carmichael; Francis L Martin
Journal:  Toxicol Sci       Date:  2019-02-01       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.